Skip Navigation LinksHome > August 2014 - Volume 19 - Issue 4 > Acceptable mismatching at the class II epitope level: the C...
Current Opinion in Organ Transplantation:
doi: 10.1097/MOT.0000000000000104
HISTOCOMPATIBILITY: Edited by RenE J. Duquesnoy

Acceptable mismatching at the class II epitope level: the Canadian experience

Wiebe, Chrisa; Nickerson, Petera,b

Collapse Box

Abstract

Purpose of review: To summarize the evidence concerning human leukocyte antigen (HLA) epitope mismatch analysis as a means to predict donor-specific antibody (DSA) development and allograft survival.

Recent findings: HLA epitope mismatch analysis outperforms traditional whole molecule antigen mismatch for predicting the risk of de-novo DSA development. By analyzing the number of epitope mismatches for a given donor-recipient pair, thresholds have been identified to stratify patients into those at high or low risk of de-novo DSA development. Epitope specificity assignment in patients who develop de-novo DSA compared with controls who do not provides an opportunity to study the relative immunogenicity of mismatched HLA epitopes.

Summary: Recognizing that de-novo DSA is a major cause of graft loss, HLA epitope mismatch analysis is a strategy to minimize de-novo DSA development and improve long-term graft survival.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.